BioMap Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 200

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 7

BioMap General Information

Description

Developer of foundation models designed to drive new drug research and development. The company utilizes artificial intelligence to allow scientists to model life more accurately from proteins to a system level and extract novel insights and predictions from limited data, supported by an international, cross-functional team, enabling physicians to enhance the effectiveness rate of new drugs.

Contact Information

Website
www.biomap.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • 2460 Embarcadero Way
  • Suite A
  • Palo Alto, CA 94303
  • United States
+1 (810)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 2460 Embarcadero Way
  • Suite A
  • Palo Alto, CA 94303
  • United States
+1 (810)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMap Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 16-Mar-2026 Announced Generating Revenue
3. Early Stage VC 24-Jun-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 30-Jul-2021 $100M $100M Completed Generating Revenue
1. Seed Round 19-Feb-2021 Completed Startup
To view BioMap’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioMap Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of foundation models designed to drive new drug research and development. The company utilizes artificial inte
Discovery Tools (Healthcare)
Palo Alto, CA
200 As of 2023

Dresden, Germany
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioMap Competitors (28)

One of BioMap’s 28 competitors is DyNAbind, a Venture Capital-Backed company based in Dresden, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DyNAbind Venture Capital-Backed Dresden, Germany
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
NeoX Biotech Venture Capital-Backed Beijing, China
Chemical Computing Group Private Equity-Backed Montreal, Canada
ProSci (Biotechnology) Private Equity-Backed Poway, CA
You’re viewing 5 of 28 competitors. Get the full list »

BioMap Patents

BioMap Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024125466-A1 Neural network training method and protein structure prediction method Inactive 12-Dec-2022

BioMap Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMap Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Granite Asia Venture Capital Minority
Hong Kong investment Sovereign Wealth Fund Minority
Lanchi Ventures Venture Capital Minority
Legend Capital Venture Capital Minority
Xiang He Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

BioMap Investments (8)

BioMap’s most recent deal was a Joint Venture with MegaStream TechBio. The deal was made on 15-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MegaStream TechBio 15-Jun-2026 Joint Venture Biotechnology
C12.ai 01-Aug-2022 Seed Round IT Consulting and Outsourcing
DPTechnology 01-Jul-2021 Early Stage VC Business/Productivity Software
AIxplorerBio 26-Apr-2021 Seed Round Drug Discovery
Neowise Biotechnology 10-Mar-2021 Early Stage VC Drug Discovery
You’re viewing 5 of 8 investments. Get the full list »

BioMap FAQs

  • When was BioMap founded?

    BioMap was founded in 2020.

  • Where is BioMap headquartered?

    BioMap is headquartered in Palo Alto, CA.

  • What is the size of BioMap?

    BioMap has 200 total employees.

  • What industry is BioMap in?

    BioMap’s primary industry is Discovery Tools (Healthcare).

  • Is BioMap a private or public company?

    BioMap is a Private company.

  • What is BioMap’s current revenue?

    The current revenue for BioMap is .

  • How much funding has BioMap raised over time?

    BioMap has raised $100M.

  • Who are BioMap’s investors?

    Granite Asia, Hong Kong investment, Lanchi Ventures, Legend Capital, and Xiang He Capital are 5 of 7 investors who have invested in BioMap.

  • Who are BioMap’s competitors?

    DyNAbind, Abcam, NeoX Biotech, Chemical Computing Group, and ProSci (Biotechnology) are some of the 28 competitors of BioMap.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process